Salix, Altana end Xifaxan deal

SLXP and Altana (FSE:ALT; AAA) terminated an agreement to co-promote SLXP's Xifaxan rifaximin 200 mg tablets to treat travelers' diarrhea. ALT said it wants to focus on respiratory therapeutics. On Mo...